Stable RNA nanoparticles as potential new generation drugs for cancer therapy.

Abstract:

:Human genome sequencing revealed that only ~1.5% of the DNA sequence coded for proteins. More and more evidence has uncovered that a substantial part of the 98.5% so-called "junk" DNAs actually code for noncoding RNAs. Two milestones, chemical drugs and protein drugs, have already appeared in the history of drug development, and it is expected that the third milestone in drug development will be RNA drugs or drugs that target RNA. This review focuses on the development of RNA therapeutics for potential cancer treatment by applying RNA nanotechnology. A therapeutic RNA nanoparticle is unique in that its scaffold, ligand, and therapeutic component can all be composed of RNA. The special physicochemical properties lend to the delivery of siRNA, miRNA, ribozymes, or riboswitches; imaging using fluogenenic RNA; and targeting using RNA aptamers. With recent advances in solving the chemical, enzymatic, and thermodynamic stability issues, RNA nanoparticles have been found to be advantageous for in vivo applications due to their uniform nano-scale size, precise stoichiometry, polyvalent nature, low immunogenicity, low toxicity, and target specificity. In vivo animal studies have revealed that RNA nanoparticles can specifically target tumors with favorable pharmacokinetic and pharmacodynamic parameters without unwanted accumulation in normal organs. This review summarizes the key studies that have led to the detailed understanding of RNA nanoparticle formation as well as chemical and thermodynamic stability issue. The methods for RNA nanoparticle construction, and the current challenges in the clinical application of RNA nanotechnology, such as endosome trapping and production costs, are also discussed.

journal_name

Adv Drug Deliv Rev

authors

Shu Y,Pi F,Sharma A,Rajabi M,Haque F,Shu D,Leggas M,Evers BM,Guo P

doi

10.1016/j.addr.2013.11.006

subject

Has Abstract

pub_date

2014-02-01 00:00:00

pages

74-89

eissn

0169-409X

issn

1872-8294

pii

S0169-409X(13)00265-2

journal_volume

66

pub_type

杂志文章,评审
  • Clinical toxicities of nanocarrier systems.

    abstract::Toxicity of nanocarrier systems involves physiological, physicochemical, and molecular considerations. Nanoparticle exposures through the skin, the respiratory tract, the gastrointestinal tract and the lymphatics have been described. Nanocarrier systems may induce cytotoxicity and/or genotoxicity, whereas their antige...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2007.11.007

    authors: Vega-Villa KR,Takemoto JK,Yáñez JA,Remsberg CM,Forrest ML,Davies NM

    更新日期:2008-05-22 00:00:00

  • Advances in nano-based inner ear delivery systems for the treatment of sensorineural hearing loss.

    abstract::Sensorineural hearing loss (SNHL) is one of the most common diseases, accounting for about 90% of all hearing loss. Leading causes of SNHL include advanced age, ototoxic medications, noise exposure, inherited and autoimmune disorders. Most of SNHL is irreversible and managed with hearing aids or cochlear implants. Alt...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2016.01.004

    authors: Li L,Chao T,Brant J,O'Malley B Jr,Tsourkas A,Li D

    更新日期:2017-01-01 00:00:00

  • Cell encapsulation: Overcoming barriers in cell transplantation in diabetes and beyond.

    abstract::Cell-based therapy is emerging as a promising strategy for treating a wide range of human diseases, such as diabetes, blood disorders, acute liver failure, spinal cord injury, and several types of cancer. Pancreatic islets, blood cells, hepatocytes, and stem cells are among the many cell types currently used for this ...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2018.04.018

    authors: Farina M,Alexander JF,Thekkedath U,Ferrari M,Grattoni A

    更新日期:2019-01-15 00:00:00

  • Selective activation of anticancer prodrugs by monoclonal antibody-enzyme conjugates.

    abstract::A great deal of interest has surrounded the activities of monoclonal antibodies (mAbs), and mAb-drug, toxin and radionuclide conjugates for the treatment of human cancers. In the last few years, a number of new mAb-based reagents have been clinically approved (Rituxan, Herceptin, and Panorex), and several others are n...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0169-409x(01)00206-x

    authors: Senter PD,Springer CJ

    更新日期:2001-12-31 00:00:00

  • Topical treatment strategies to manipulate human skin pigmentation.

    abstract::Skin pigmentation is a result of melanin produced by melanocytes in the epidermis. Melanocyte activity, along with the type and distribution of melanins, is the main driver for diversity of skin pigmentation. Dark melanin acts to protect against the deleterious effects of ultraviolet (UV) radiation, including photo-ag...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2020.02.002

    authors: Rachmin I,Ostrowski SM,Weng QY,Fisher DE

    更新日期:2020-01-01 00:00:00

  • Acceptability and preferences for vaginal dosage forms intended for prevention of HIV or HIV and pregnancy.

    abstract::This paper reviews key issues found to affect acceptability and preferences for vaginal products to prevent HIV infection or HIV and pregnancy. We focus on the interplay between the biological and physico-chemical aspects of formulation and the social and behavioral issues that may affect use. The need for an HIV prev...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2015.02.004

    authors: Woodsong C,Holt JD

    更新日期:2015-09-15 00:00:00

  • Gene delivery to bone.

    abstract::Gene delivery to bone is useful both as an experimental tool and as a potential therapeutic strategy. Among its advantages over protein delivery are the potential for directed, sustained and regulated expression of authentically processed, nascent proteins. Although no clinical trials have been initiated, there is a s...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2012.03.013

    authors: Evans CH

    更新日期:2012-09-01 00:00:00

  • Stem-cell based organ-on-a-chip models for diabetes research.

    abstract::Diabetes mellitus (DM) ranks among the severest global health concerns of the 21st century. It encompasses a group of chronic disorders characterized by a dysregulated glucose metabolism, which arises as a consequence of progressive autoimmune destruction of pancreatic beta-cells (type 1 DM), or as a result of beta-ce...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2018.10.010

    authors: Rogal J,Zbinden A,Schenke-Layland K,Loskill P

    更新日期:2019-02-01 00:00:00

  • Biomimetic materials and micropatterned structures using iniferters.

    abstract::In the preparation of biomimetic materials it is often required that efficient methods of polymerization be used, often methods that can lead to biomimetic polymers with relatively narrow molecular weight distribution. Living radical polymerization techniques have successfully been used to create low polydispersity li...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2003.10.046

    authors: Peppas NA,Ward JH

    更新日期:2004-09-22 00:00:00

  • Intestinal epithelial tight junctions as targets for enteric bacteria-derived toxins.

    abstract::The application of a multidisciplinary approach to study bacterial pathogenesis, along with the recent sequencing of entire microbial genomes have made possible discoveries that are changing the way scientists view the bacterium-host interaction. Today, research on the molecular basis of the pathogenesis of infectious...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2003.10.045

    authors: Fasano A,Nataro JP

    更新日期:2004-04-19 00:00:00

  • Targeting drug delivery in the vascular system: Focus on endothelium.

    abstract::The bloodstream is the main transporting pathway for drug delivery systems (DDS) from the site of administration to the intended site of action. In many cases, components of the vascular system represent therapeutic targets. Endothelial cells, which line the luminal surface of the vasculature, play a tripartite role o...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2020.06.013

    authors: Glassman PM,Myerson JW,Ferguson LT,Kiseleva RY,Shuvaev VV,Brenner JS,Muzykantov VR

    更新日期:2020-01-01 00:00:00

  • Unintended and in situ amorphisation of pharmaceuticals.

    abstract::Amorphisation of poorly water-soluble drugs is one approach that can be applied to improve their solubility and thus their bioavailability. Amorphisation is a process that usually requires deliberate external energy input. However, amorphisation can happen both unintentionally, as in process-induced amorphisation duri...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2015.12.014

    authors: Priemel PA,Grohganz H,Rades T

    更新日期:2016-05-01 00:00:00

  • Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer.

    abstract::The recent developments of nuclear medicine in oncology have involved numerous investigations of novel specific tumor-targeting radiopharmaceuticals as a major area of interest for both cancer imaging and therapy. The current progress in pharmaceutical nanotechnology field has been exploited in the design of tumor-tar...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2008.04.013

    authors: Hamoudeh M,Kamleh MA,Diab R,Fessi H

    更新日期:2008-09-01 00:00:00

  • Investigation of endosome and lysosome biology by ultra pH-sensitive nanoprobes.

    abstract::Endosomes and lysosomes play a critical role in various aspects of cell physiology such as nutrient sensing, receptor recycling, protein/lipid catabolism, and cell death. In drug delivery, endosomal release of therapeutic payloads from nanocarriers is also important in achieving efficient delivery of drugs to reach th...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2016.08.014

    authors: Wang C,Zhao T,Li Y,Huang G,White MA,Gao J

    更新日期:2017-04-01 00:00:00

  • Aptamers as targeting ligands and therapeutic molecules for overcoming drug resistance in cancers.

    abstract::Traditional anticancer therapies are often unable to completely eradicate the tumor bulk due to multi-drug resistance (MDR) of cancers. A number of mechanisms such as micro-environmental stress and overexpression of drug efflux pumps are involved in the MDR process. Hence, therapeutic strategies for overcoming MDR are...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2018.04.005

    authors: Zhou G,Latchoumanin O,Hebbard L,Duan W,Liddle C,George J,Qiao L

    更新日期:2018-09-01 00:00:00

  • Imaging mass spectrometry: from tissue sections to cell cultures.

    abstract::Imaging mass spectrometry (IMS) has been a useful tool for investigating protein, peptide, drug and metabolite distributions in human and animal tissue samples for almost 15years. The major advantages of this method include a broad mass range, the ability to detect multiple analytes in a single experiment without the ...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2013.03.006

    authors: Weaver EM,Hummon AB

    更新日期:2013-07-01 00:00:00

  • Thioredoxin 1 delivery as new therapeutics.

    abstract::Thioredoxin 1 (Trx 1) is a redox-active small protein ubiquitously present in human body. It is one of the defensive proteins induced in response to various stress conditions. In addition to its anti-oxidative effect by dithiol-disulfide exchange in its active site, Trx 1 has anti-apoptotic and anti-inflammatory effec...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2009.01.003

    authors: Nakamura H,Hoshino Y,Okuyama H,Matsuo Y,Yodoi J

    更新日期:2009-04-28 00:00:00

  • The biology of mucus: Composition, synthesis and organization.

    abstract::In this review we discuss mucus, the viscoelastic secretion from goblet or mucous producing cells that lines the epithelial surfaces of all organs exposed to the external world. Mucus is a complex aqueous fluid that owes its viscoelastic, lubricating and hydration properties to the glycoprotein mucin combined with ele...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2017.09.023

    authors: Bansil R,Turner BS

    更新日期:2018-01-15 00:00:00

  • Modeling transdermal drug release.

    abstract::The stratum corneum forms the outermost layer of the skin and is essentially a multilamellar lipid milieu punctuated by protein-filled corneocytes that augment membrane integrity and significantly increase membrane tortuosity. The lipophilic character of the stratum corneum, coupled with its intrinsic tortuosity, ensu...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0169-409x(01)00113-2

    authors: Kalia YN,Guy RH

    更新日期:2001-06-11 00:00:00

  • Risk assessment of neonatal excipient exposure: lessons from food safety and other areas.

    abstract::Newborn babies can require significant amounts of medication containing excipients intended to improve the drug formulation. Most medicines given to neonates have been developed for adults or older children and contain excipients thought to be safe in these age groups. Many excipients have been used widely in neonates...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章

    doi:10.1016/j.addr.2013.11.003

    authors: Turner MA,Duncan JC,Shah U,Metsvaht T,Varendi H,Nellis G,Lutsar I,Yakkundi S,McElnay JC,Pandya H,Mulla H,Vaconsin P,Storme T,Rieutord A,Nunn AJ

    更新日期:2014-06-01 00:00:00

  • Innate immunity activation on biomaterial surfaces: a mechanistic model and coping strategies.

    abstract::When an artificial biomaterial (e.g., a stent or implantable pump) is exposed to blood, plasma proteins immediately adhere to the surface, creating a new interface between the biomaterial and the blood. The recognition proteins within the complement and contact activation/coagulation cascade systems of the blood will ...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2011.06.012

    authors: Ekdahl KN,Lambris JD,Elwing H,Ricklin D,Nilsson PH,Teramura Y,Nicholls IA,Nilsson B

    更新日期:2011-09-16 00:00:00

  • The biochemical and physiological characteristics of receptors.

    abstract::Cell surface receptors play a central role in the regulation of both cellular and systemic physiology by mediating intercellular communication, facilitating protein trafficking, and regulating virtually all intracellular processes. Receptor expression is often cell specific and is determined by cellular lineage, genet...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章

    doi:10.1016/s0169-409x(97)00079-3

    authors: King GL,Feener EP

    更新日期:1998-02-02 00:00:00

  • The transport of antiepileptic drugs by P-glycoprotein.

    abstract::Epilepsy is the most common serious chronic neurological disorder. Current data show that one-third of patients do not respond to anti-epileptic drugs (AEDs). Most non-responsive epilepsy patients are resistant to several, often all, AEDs, even though the drugs differ from each other in pharmacokinetics, mechanisms of...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2011.12.003

    authors: Zhang C,Kwan P,Zuo Z,Baum L

    更新日期:2012-07-01 00:00:00

  • Critical analysis of 3-D organoid in vitro cell culture models for high-throughput drug candidate toxicity assessments.

    abstract::Drug failure due to toxicity indicators remains among the primary reasons for staggering drug attrition rates during clinical studies and post-marketing surveillance. Broader validation and use of next-generation 3-D improved cell culture models are expected to improve predictive power and effectiveness of drug toxico...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2014.02.008

    authors: Astashkina A,Grainger DW

    更新日期:2014-04-01 00:00:00

  • Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead.

    abstract::One of the most common causes of illnesses in humans is from respiratory tract infections caused by bacterial, viral or fungal pathogens. Inhaled anti-infective drugs are crucial for the prophylaxis and treatment of respiratory tract infections. The benefit of anti-infective drug delivery via inhalation is that it aff...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2014.11.004

    authors: Velkov T,Abdul Rahim N,Zhou QT,Chan HK,Li J

    更新日期:2015-05-01 00:00:00

  • Strategies for controlled delivery of biologics for cartilage repair.

    abstract::The delivery of biologics is an important component in the treatment of osteoarthritis and the functional restoration of articular cartilage. Numerous factors have been implicated in the cartilage repair process, but the uncontrolled delivery of these factors may not only reduce their full reparative potential but can...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2014.06.006

    authors: Lam J,Lu S,Kasper FK,Mikos AG

    更新日期:2015-04-01 00:00:00

  • Ethical, legal, and social implications (ELSI) of microdose clinical trials.

    abstract::A "microdose clinical trial" (microdosing) is one kind of early phase exploratory clinical trial, administering the compound at doses estimated to have no pharmacological or toxicological effects, aimed at screening candidates for further clinical development. This article's objective is to clarify the ethical, legal,...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2011.01.002

    authors: Kurihara C

    更新日期:2011-06-19 00:00:00

  • Caveolae as potential macromolecule trafficking compartments within alveolar epithelium.

    abstract::With inhalational delivery the alveolar epithelium appears to be the appropriate lung surface to target for the systemic delivery of macromolecules, such as therapeutic proteins. The existence of a high numerical density of smooth-coated or non-coated plasma membrane vesicles or invaginations within the alveolar epith...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0169-409x(01)00142-9

    authors: Gumbleton M

    更新日期:2001-07-28 00:00:00

  • P-glycoprotein, secretory transport, and other barriers to the oral delivery of anti-HIV drugs.

    abstract::Orally administered anti-HIV drugs must be adequately and consistently absorbed for therapy to be successful. This review discusses the barriers to achieving oral bioavailability for the currently available anti-HIV drugs. Most reverse transcriptase inhibitors have good oral bioavailabilities. Didanosine bioavailabili...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章

    doi:10.1016/s0169-409x(99)00022-8

    authors: Aungst BJ

    更新日期:1999-10-18 00:00:00

  • Arterial gene transfer of naked DNA for therapeutic angiogenesis: early clinical results.

    abstract::Patients with critical limb ischemia constitute a potential target population for therapeutic angiogenesis. Because the growth of new collateral vessels can be achieved in a time interval of 1 month or less, these patients are suitable candidates for treatment with non-viral vectors intended to yield short-term gene e...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章

    doi:10.1016/s0169-409x(97)00115-4

    authors: Isner JM

    更新日期:1998-03-02 00:00:00